148 related articles for article (PubMed ID: 1389526)
21. Single-photon emission computed tomography quantitation of gallium citrate uptake for the differentiation of lymphoma from benign hilar uptake.
Even-Sapir E; Bar-Shalom R; Israel O; Frenkel A; Iosilevsky G; Haim N; Epelbaum R; Gaitini D; Kolodny GM; Front D
J Clin Oncol; 1995 Apr; 13(4):942-6. PubMed ID: 7707122
[TBL] [Abstract][Full Text] [Related]
22. Mediastinal neurilemmoma demonstrated by positive Tc-99m(V) DMSA SPECT and negative Ga-67 uptake.
Lee BF; Chiu NT; Huang MS; Liu GC; Yu HS
Clin Nucl Med; 2000 Apr; 25(4):292-4. PubMed ID: 10750973
[No Abstract] [Full Text] [Related]
23. Ga-67 SPECT before and after treatment of lymphoma.
Front D; Israel O; Epelbaum R; Ben Haim S; Sapir EE; Jerushalmi J; Kolodny GM; Robinson E
Radiology; 1990 May; 175(2):515-9. PubMed ID: 2183289
[TBL] [Abstract][Full Text] [Related]
24. Technetium-99m depreotide imaging by single photon emission tomography/low resolution computed tomography in malignant lymphomas: comparison with gallium-67 citrate.
Apostolopoulos DJ; Papandrianos NI; Symeonidis A; Spyridonidis T; Alexiou S; Zampakis P; Savvopoulos C; Vassilakos PJ; Matsouka P
Ann Nucl Med; 2010 Nov; 24(9):639-47. PubMed ID: 20799079
[TBL] [Abstract][Full Text] [Related]
25. Thoracic CT-scanning follow-up of residual mediastinal masses after treatment of Hodgkin's disease.
Thomas F; Cosset JM; Cherel P; Renaudy N; Carde P; Piekarski JD
Radiother Oncol; 1988 Feb; 11(2):119-22. PubMed ID: 3353516
[TBL] [Abstract][Full Text] [Related]
26. Massive mediastinal Hodgkin's disease with calcification masquerading teratocarcinoma: differentiation by computed tomography.
Shin MS; Branscomb BV; Ho KJ
J Comput Tomogr; 1985 Oct; 9(4):321-7. PubMed ID: 4053660
[TBL] [Abstract][Full Text] [Related]
27. Comparison of 18F-fluoro-2-deoxyglucose positron emission tomography and gallium-67 citrate scintigraphy for detecting malignant lymphoma.
Shen YY; Kao A; Yen RF
Oncol Rep; 2002; 9(2):321-5. PubMed ID: 11836600
[TBL] [Abstract][Full Text] [Related]
28. Ga-67 scintigraphy in a rare case of primary pleural Hodgkin's lymphoma.
Bernstine H; Bar-Sever Z; Ekstein J; Hardoff R
Clin Nucl Med; 1999 Nov; 24(11):880-1. PubMed ID: 10551472
[No Abstract] [Full Text] [Related]
29. [Value of endoscopic ultrasound examination of the mediastinum in Hodgkin's and non-Hodgkin's lymphomas].
Zimmer T; Patan M; Berdel WE; Dulce MC; Riecken EO
Ultraschall Med; 1997 Apr; 18(2):67-71. PubMed ID: 9304199
[TBL] [Abstract][Full Text] [Related]
30. Gallium scan in adolescents and children with Hodgkin's disease (HD). Treatment response assessment and prognostic value.
Castellani MR; Cefalo G; Terenziani M; Aliberti G; Maccauro M; Alessi A; Villano C; Bombardieri E
Q J Nucl Med; 2003 Mar; 47(1):22-30. PubMed ID: 12714951
[TBL] [Abstract][Full Text] [Related]
31. Mediastinal lymph node metastasis from lung cancer: evaluation with Tl-201 SPECT--comparison with CT.
Yokoi K; Okuyama A; Mori K; Tominaga K; Miyazawa N; Takizawa I; Sasagawa M
Radiology; 1994 Sep; 192(3):813-7. PubMed ID: 8058953
[TBL] [Abstract][Full Text] [Related]
32. Negative gallium-67 citrate and positive positron emission tomography/computed tomography spleen scans, in Hodgkin's stage IV lymphoma.
Malamitsi J; Kosmidis H; Valotassiou B; Bonou I; Andreou J
Hell J Nucl Med; 2007; 10(2):116-8. PubMed ID: 17684589
[TBL] [Abstract][Full Text] [Related]
33. Diagnostic role of gallium scanning in the management of lymphoma with mediastinal involvement.
Zinzani PL; Magagnoli M; Franchi R; Zompatori M; Frezza G; Galassi R; Gherlinzoni F; Bendandi M; Albertini P; Monetti N; Tura S
Haematologica; 1999 Jul; 84(7):604-7. PubMed ID: 10406901
[TBL] [Abstract][Full Text] [Related]
34. Negative predictive value of gallium-67 SPET/CT in a case of Hodgkin's lymphoma with bulky mediastinal disease.
Harisankar CN; Kamaleshwaran KK; Bhattacharya A; Singh B; Mittal BR
Hell J Nucl Med; 2009; 12(1):64-5. PubMed ID: 19330188
[No Abstract] [Full Text] [Related]
35. Recurrent mediastinal mass in a child with Hodgkin's disease following successful therapy: a diagnostic challenge.
Feldges A; Wagner HP; Bubeck B; Kehrer B; Ries G; Schmid U; Waibel P
Pediatr Surg Int; 1997; 12(8):613-7. PubMed ID: 9354739
[TBL] [Abstract][Full Text] [Related]
36. Hodgkin disease: use of Tl-201 to monitor mediastinal involvement after treatment.
Fletcher BD; Xiong X; Kauffman WM; Kaste SC; Hudson MM
Radiology; 1998 Nov; 209(2):471-5. PubMed ID: 9807576
[TBL] [Abstract][Full Text] [Related]
37. Gallium scan in the evaluation of post chemotherapy mediastinal residual masses of aggressive non-Hodgkin's lymphoma.
Ulusakarya A; Lumbroso J; Casiraghi O; Koscielny S; Vantelon JM; Girinsky T; Tardivon A; Bourhis JH; Dartevelle P; Pico JL; Munck JN
Leuk Lymphoma; 1999 Nov; 35(5-6):579-86. PubMed ID: 10609795
[TBL] [Abstract][Full Text] [Related]
38. Cystic Hodgkin's lymphoma of the thymus: computed tomography appearance.
Federle MP; Callen PW
J Comput Assist Tomogr; 1979 Aug; 3(4):542-4. PubMed ID: 457971
[TBL] [Abstract][Full Text] [Related]
39. Hodgkin's disease: internal mammary lymph nodes relapse diagnosed by gallium-67 scintigraphy.
Ruíz Hernández G; Pallardó Y; García Conde J; Ramos D; Ampudia J; Castillo FJ; Romero C
Nuklearmedizin; 1999 Apr; 38(3):90-4. PubMed ID: 10320995
[TBL] [Abstract][Full Text] [Related]
40. [Semiology of the exploration of residual masses in the mediastinum using imaging techniques].
Pallardó Calatayud Y; Ferrer Puchol MD; García Conde J
Sangre (Barc); 1998 Feb; 43(1):83-6. PubMed ID: 9577187
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]